Bio-Rad Laboratories Inc. (BIO) Misses Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $372.18 -3.18%
EPS Growth %: -1.3%
Financial Fact:
Weighted average common shares - diluted: 29.59M
Today's EPS Names:
OPY, BNCC, ZVOI, More
EPS Growth %: -1.3%
Financial Fact:
Weighted average common shares - diluted: 29.59M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q1 EPS of $1.09, $0.02 worse than the analyst estimate of $1.11. Revenue for the quarter came in at $486.3 million versus the consensus estimate of $492.35 million.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Arm Holdings stock sinks amid broad chip sector selloff
- Freedom Broker Downgrades RPC Inc. (RES) to Sell
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
